Sort
17,288 grants matching “multiple sclerosis”
Molecular basis for functional S1PR1 antagonists in the treatment of comorbid migraine and temporomandibular disorders
$570,062Simon Akerman · University Of Maryland Baltimore · R01 · FY2025 · NS
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
$570,031William H Robinson · Stanford University · R01 · FY2025 · AI
Refining Mendelian disease analysis via detection of clinically relevant repeat variants
$570,000Melissa Gymrek · University Of California, San Diego · R01 · FY2020 · HG
Refining Mendelian disease analysis via detection of clinically relevant repeat variants
$570,000Melissa Gymrek · University Of California, San Diego · R01 · FY2021 · HG
Refining Mendelian disease analysis via detection of clinically relevant repeat variants
$570,000Melissa Gymrek · University Of California, San Diego · R01 · FY2018 · HG
Refining Mendelian disease analysis via detection of clinically relevant repeat variants
$570,000Melissa Gymrek · University Of California, San Diego · R01 · FY2019 · HG
Minocycline Immune Effects on SIV CNS Disease
$569,902M Christine Zink · Johns Hopkins University · R01 · FY2012 · MH
Role of T Cells in Lung Disease in Systemic Sclerosis
$569,755University Of Maryland Baltimore · R01 · FY2004 · HL
SIGNAL TRANSDUCTION TO P70 S6 KINASE 1
$569,601John Blenis · Harvard Medical School · R01 · FY2006 · GM
SIGNAL TRANSDUCTION TO P70 S6 KINASE 1
$569,579John Blenis · Harvard Medical School · R01 · FY2007 · GM
ACQUIRED &GENETIC DETERMINANTS OF MULTIPLE SCLEROSIS
$569,458University Of Southern California · R01 · FY2002 · NS
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
$569,090Marisa McGinley · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · NR
Minocycline Immune Effects on SIV CNS Disease
$569,074M Christine Zink · Johns Hopkins University · R01 · FY2014 · MH
Immunology of advancing disease among minorities with Multiple Sclerosis
$569,072Nancy L Monson · Ut Southwestern Medical Center · R01 · FY2021 · NS
Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain
$569,055Irving J Bigio · Boston University (Charles River Campus) · R01 · FY2022 · AG
Cognitive neural prosthetics for clinical applications
$568,989Richard A Andersen · California Institute Of Technology · R01 · FY2010 · EY
Molecular and Cellular Mechanisms of Calcific Aortic Stenosis
$568,927Bin Zhou · Albert Einstein College Of Medicine · R01 · FY2013 · HL
Brain Oxygen Metabolism and Hemodynamic Impairment in Multiple Sclerosis
$568,920Yulin Ge · New York University School Of Medicine · R01 · FY2012 · NS
Quantification of the Innate Immune Activity within Chronic Lesions as a Novel Treatment Biomarker in Multiple Sclerosis
$568,701Susan A Gauthier · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
Stress Effects on Virus Protein induced Inflammation and Sickness Behavior
$568,411Marshall Vance Williams · Ohio State University · R01 · FY2016 · AI
Stress Effects on Virus Protein induced Inflammation and Sickness Behavior
$568,411Marshall Vance Williams · Ohio State University · R01 · FY2017 · AI
Stress Effects on Virus Protein induced Inflammation and Sickness Behavior
$568,411Marshall Vance Williams · Ohio State University · R01 · FY2019 · AI
Postmortem Pathology
$568,336David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots
$568,324Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2022 · AI
TNF-receptors and programmed cell death in regulation of autoimmunity
$568,218Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR